A case of acquired iris depigmentation as a possible complication of levobunolol eye drops.
Doyle
E
E
Liu
C
C
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced; D007499:Iris Diseases / Q000139:chemically induced*; D002040:Levobunolol / Q000009:adverse effects*; D008297:Male; D010859:Pigmentation Disorders / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D002040:Levobunolol